- Home
- /
- Treatment
- /
- Page 124
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Beraprost | Pulmonary Arterial Hypertension | LungRx, Inc.;1040 Spring Street;Silver Spring, Maryland, 20910 | April 29, 1999 | |
CT-2584 mesylate | Malignant mesothelioma | Cell Therapeutics, Inc.;501 Elliott Avenue West, #400;Seattle, Washington, 98119 | April 16, 1999 | |
CT-2584 Mesylate | Adult soft tissue sarcoma | Cell Therapeutics, Inc.;501 Elliott Avenue West, #400;Seattle, Washington, 98119 | April 16, 1999 | |
Recombinant human nerve growth factor | HIV-associated sensory neuropathy | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | April 16, 1999 | |
Rifalazil | Pulmonary tuberculosis | PathoGenesis Corporation;201 Elliott Avenue West, Suite 150;Seattle, Washington, 98119 | April 13, 1999 | |
Pegylated arginine deiminase | Invasive malignant melanoma | Polaris Pharmaceuticals, Inc.;A Polaris Group Company, Suite 106;San Diego, California, 92121 | April 12, 1999 | |
Recombinant replication deficient adenovirus vector carrying human p53 gene | Primary ovarian cancer | Schering Corporation;2000 Galloping Hill Rd.;Kenilworth, New Jersey, 07033 | April 12, 1999 | |
Eprodisate | Amyloidosis | C. T. Development America, Inc.;663 Fifth Avenue, 7th Floor;New York, New York, 10022 | April 6, 1999 | |
Thalidomide | Crohn's disease | Celgene Corporation;7 Powder Horn Dr.;Warren | April 6, 1999 | |
6-hydroxymethylacylfulvene | Histologically confirmed advanced or metastatic pancreatic cancer | Eisai, Inc.;300 Tice Blvd;Woodcliff Lake, New Jersey, 07677 | April 6, 1999 | |
Etanercept | Wegener’s Granulomatosis | Immunex Corporation;51 University Street;Seattle, Washington, 98101 | April 6, 1999 | |
Epoprostenol | Secondary pulmonary hypertension | GlaxoSmithKline;2301 Renaissance Blvd, P. O. Box 61540;King of Prussia, Pennsylvania, 19406 | March 22, 1999 | |
Recombinant humanized MAb 5c8 | Prevention of rejection of solid organ transplants | Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142 | March 22, 1999 | |
Recombinant humanized MAb 5c8 | Prevention of rejection of pancreatic islet cell transplants | Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142 | March 22, 1999 | |
Murine MAb to polymorphic epithelial mucin, human milk fat globule 1 | Adjuvant treatment of ovarian cancer | Antisoma plc;West Africa House, Hanger Lane Ealing;London W5 3QR | March 22, 1999 | |
Decitabine | Chronic myeloid leukemia | Otsuka Pharmaceutical Development &;Commercialization, Inc., 508 Carnegie Center Drive;Princeton, New Jersey, 08540 | March 8, 1999 | |
Decitabine | Myelodysplastic syndromes | Otsuka Pharmaceutical Development;and Commercialization, Inc., 508 Carnegie Center Drive;Princeton, New Jersey, 08540 | March 8, 1999 | |
Autologous DNP-conjugated tumor vaccine | Metastatic Melanoma | Avax Technologies, Inc.;9200 Indian Creek Parkway, Building 9, Suite 200;Overland Park, Kansas, 66210 | February 23, 1999 | |
Recombinant human C1-esterase inhibitor | Hereditary angioedema | Pharming Group N.V.;P. O. Box 451 Darwinweg 24, 2300 Al Leiden;Leiden | February 23, 1999 | |
C1-esterase inhibitor (recombinant) | Hereditary angioedema | Pharming Group N.V.;P. O. Box 451 Darwinweg 24, 2300 Al Leiden;Leiden | February 23, 1999 | |
N-acetylgalactosamine-4-sulfatase, recombinant human | Mucopolysaccharidosis type VI | BioMarin Pharmaceutical, Inc.;105 Digital Drive;Novato, California, 94949 | February 17, 1999 | |
Iodine I-131 radiolabeled chimeric MAb tumor necrosis treatment (TNT-1B) | Glioblastoma | Peregrine Pharmaceuticals, Inc.;14282 Franklin Ave.;Tustin, California, 92780 | February 12, 1999 | |
Chelating agent delivering Holmium-166 | Multiple myeloma | NeoRx Corporation;410 W. Harrison Street;Seattle, Washington, 98119 | February 10, 1999 | |
Humanized MAb (IDEC-131) to CD40L | Systemic lupus erythematosus | Biogen IdecInc.;3030 Callan Rd.;San Diego, California, 92121 | February 9, 1999 | |
Bleomycin | Pancreatic cancer | Genetronics, Inc.;11199 Sorrento Valley Rd.;San Diego, California, 92121 | February 9, 1999 |